|
KURAMOCHI HIDEKAZU
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Position Associate Professor |
|
| Article types | Original article |
| Language | English |
| Peer review | Peer reviewed |
| Title | Phase II study of bevacizumab and irinotecan as second-line therapy for patients with metastatic colorectal cancer previously treated with fluoropyrimidines, oxaliplatin, and bevacizumab. |
| Journal | Formal name：Cancer chemotherapy and pharmacology Abbreviation：Cancer Chemother Pharmacol ISSN code：(1432-0843)0344-5704(Linking) |
| Domestic / Foregin | Foregin |
| Volume, Issue, Page | 79(3),pp.579-585 |
| Author and coauthor | Kuramochi Hidekazu, Ando Masayuki, Itabashi Michio, Nakajima Go, Kawakami Kazuyuki, Hamano Mie, Hirai Eiichi, Yokomizo Hajime, Okuyama Ryuji, Araida Tatsuo, Yoshimatsu Kazuhiko, Kameoka Shingo, Hayashi Kazuhiko |
| Publication date | 2017/03 |
| Summary | UMIN000005228. |
| DOI | 10.1007/s00280-017-3255-3 |
| PMID | 28213683 |